The inflation impact visible in Hippo Holdings HIPO results Q1 2026 EPS Beats Forecasts LanzaTech LNZAW Stock Affects Direction 1257 20260420 WaFd WAFD Stock Technical Outlook Q1 2026 EPS Exceeds Expectations TBPH Theravance Biopharma notches 669 Q4 2025 revenue growth despite large EPS miss stock dips marginally JEF Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Adjustments MUR Q1 2026 Earnings Murphy Oil Beats EPS Estimates but Shares Fall 31 Japans Plastic Industry Faces Rising Risks From Strait of Hormuz Disruption Yalla YALA Stock Analysis Falls 348 Watching 579 20260520 Consumer Credit Growth Accelerates in December Fed Data Shows Ethereum Price on May 26 2026 Market Snapshot at a Key Juncture Home Depot Comparable Sales Catch Lowes Potentially Lifting Stock Performance Photronics The Unheralded Semiconductor Stock Quietly Delivering 17 Annual Returns Novartis Raises Annual Sales and Profit Guidance on Strong Performance Bitcoin and Ethereum Prices Hold Steady in Quiet Trading Week as Peace Signals Awaited RCI Hospitality Holdings Q3 2025 Earnings Deep EPS Miss Amidst Operating Headwinds Wetouch Technology Inc Q1 1996 Earnings EPS Falls Short of Estimates Stock Rises on Speculative Optimism GPRE Q1 2026 Earnings Record EPS Surprise of 63555 Highlights Operational Efficiency NeoVolta Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Rises SOWG Q3 2025 Earnings Significant EPS Miss Sends Shares Lower ZTS Q1 2026 Earnings EPS Falls Short of Expectations as Stock Edges Higher Fox Factory FOXF Rebounds 264 From Support Key Resistance at 1755 in Focus Cantor Equity Partners I Inc CEPO Edges Higher as Stock Consolidates Near Key Levels Genenta Science GNTA Surges 9 Testing Key Resistance at 095 Advanced Drainage Systems WMS Shares Jump 34 Support Holds and Resistance in Focus Gates Industrial GTES Slides 326 as Selling Pressure Intensifies Wholesale Inflation Surges to 6 in April Marking Biggest Annual Gain Since 2022 BMRA Q1 2026 Earnings Loss of 044 Per Share Amid No Revenue Disclosure CanFite Biopharma CANF Slides 262 Toward 318 Support as Selling Pressure Persists